Tema Oncology ETF CANC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +21.80%
- 1 year
- +37.57%
- Open
- 42.25
- Prev close
- 42.33
- Mkt cap
- 134.36M
- Vol
- 24.93K
- Avg vol
- 24.45K
- EPS
- 1.59
- P/E
- 26.60
- Div yield
- 0.00%
More statistics
- Low
- 42.00
- High
- 43.07
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 27.30
- 200-d avg
- 27.72
News
1 month ago benzinga.com
EXCLUSIVE: AI, Genomics Could Fuel Biotech ETF Re-Rating as Health Care Trades at Discount, Says Expert
AI and genomics could fuel a biotech ETF re-rating as health care trades at a discount, says Dr. David Song, MD, PhD.
2 months ago zacks.com
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.
2 months ago zacks.com
Biotech ETF (CANC) Hits New 52-Week High
CANC hits a 52-week high as strong oncology developments and positive momentum fuel the biotech ETF's rally.
4 months ago businesswire.com
Tema ETFs Exceeds $5bn in AUM After Three Years
NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, has surpassed $5 billion in assets under management (AUM) three years…
6 months ago businesswire.com
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years
NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced that the firm has surpassed $2 billion in assets under…
6 months ago seekingalpha.com
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks
Tema Oncology ETF receives a Hold rating due to inconsistent returns but it does currently have a high Quant Ranking in the healthcare subclass. CANC offers diversified exposure across market caps…
8 months ago businesswire.com
Tema Appoints ETF Industry Leader Steve Munroe as President
NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced the appointment of Steve Munroe as President. In this…
8 months ago defenseworld.net
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC
Thrivent Financial for Lutherans cut its holdings in shares of Tema Oncology ETF (NASDAQ: CANC) by 84.6% in the undefined quarter, according to its most recent disclosure with the Securities and…
11 months ago businesswire.com
Tema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance
NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (“CANC”) has surpassed $100m in…
11 months ago benzinga.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly
Large pharma companies are facing severe patent cliffs, where blockbuster drugs lose exclusivity and revenue plummets.
11 months ago zacks.com
Be Thankful to These ETFs This Year
Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.
1 year ago etftrends.com
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical…
3 years ago zacks.com
Inside Tema ETFs' New Oncology ETF (CANC)
Oncology treatment has witnessed remarkable progress due to the relentless efforts of pharmaceutical companies in recent times.
3 years ago etftrends.com
This Week in ETFs: 2 New Funds Launch From Tema
The U.S. ETF industry saw a major slowdown in ETF launches during the week ending Aug. 18 as the summer slump continued. Only six new ETFs launched, while issuers announced only one new closure.